For press inquiries click here to contact us.
Fortune
Diabetes-Focused ‘Unicorn’ Intarcia Makes Its First-Ever Acquisition
FierceBiotech
Biotech Intarcia’s Diabetes-Treating Implant Tops Januvia In A Head-to-Head Test
Bloomberg
Intarcia’s Diabetes Implant Beats Januvia In Trial
The Wall Street Journal
Intarcia’s Diabetes Treatment Clears Key Test
FierceBiotech
Aimmune Therapeutics Receives FDA Breakthrough Therapy Designation For AR101
Bloomberg
Aimmune’s Peanut Allergy Drug Desensitizes Patients In Trial
FierceBiotech
Gene Therapy Pioneer ReGenX Raises $70.5M To Go It Alone
CNBC
The Holy Grail Of Treating Disease: Intarcia
MarketWatch
Next Generation Sequencing (NGS) Markets 2015
Please see important disclaimers in the Terms section.
